Orforglipron
-
Orforglipron
structure -
-
CAS No:
2212020-52-3
-
Formula:
C48H48F2N10O5
-
Chemical Name:
Orforglipron
-
Synonyms:
1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy...;LY3502970;GLP-1 receptor agonist 1 USP/EP/BP;Orforglipron;Orforglipron(LY3502970);LY3502970 (Orforglipron);3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one;OWL 833
-
Categories:
Active Pharmaceutical Ingredients > Hormones and the Endocrine System
-
CAS No:
Description
Orforglipron (LY3502970) (GLP-1 receptor agonist 1) is GLP-1 receptor agonist extracted from patent WO2018056453A1, Compound 67.
Orforglipron is an oral, non-peptide, small-molecule glucagon-like peptide-1 receptor agonist developed by Eli Lilly and Company as a weight-loss drug. Currently, the drug is still in Phase III clinical trials and has not yet received approval from the U.S. Food and Drug Administration (FDA). Eli Lilly's CEO expects the FDA to approve its investigational oral weight-loss drug, orforglipron, by March 2026, and to submit an application for the treatment of type 2 diabetes by the end of 2026.
Orforglipron Use and Manufacturing
Orforglipron is a non-peptide oral glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used in the management of type 2 diabetes mellitus (T2DM) and obesity. In T2DM patients, the drug reduces glycated haemoglobin (HbA1c) by up to 2.10%, facilitates weight loss of up to 10.1 kilograms, and reduces waist circumference by up to 8.7 centimetres. Studies in overweight or obese populations indicate weight loss of up to 13.0 kilograms. Adverse reactions include mild to moderate vomiting and nausea, particularly common following high-dose therapy or rapid dose escalation. Consequently, it should be used cautiously under medical supervision.
Glucagon-like peptide-1 (GLP-1) agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity.
Recommended Suppliers of Orforglipron
-
HK
2 YRS
Business licensedTrader Supplier of Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332,Orforglipron,Pharmaceutical intermediates,Aniracetam,Paraxanthine,AF710B,Clascoterone,TAK-653,PRL-8-53InquiryUnit Price: $22-24 /G FOBCAS No.: 2212020-52-3Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Agrochemicals,Daily Chemicals,Catalysts & Chemical Auxiliary Agents,Extract,Inorganic Chemicals,Organic Intermediate,Pigment & Dyestuff,Polymer,Flavour & Fragrance,Basic Organic Chemicals,Pharmaceutical -
CN
2 YRS
Business licensedTrader Supplier of Semaglutide,Tirzepatide,Lixisenatide,Teduglutide,Retatrutide,Tirzepatide,Cagrilintide,Linaclotide,Octreotide Acetate,Sincalide,L- LYSINE MONOHYDRATE -
CN
1 YR
Business licensedTrader Supplier of Peptides,API,Intermediate -
CN
2 YRS
Business licensedTrader Supplier of pharmaceutical intermediates,excipients,plant extracts,food additives,CDMO,fine cheimcals,Octadecanedioic acid,Eicosanedioic AcidInquiryCAS No.: 2212020-52-3Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
Cevimeline hydrochloride
107220-28-0
-
1-Butanone, 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-, (2E)-2-butenedioate (1:1)
97928-20-6
-
Timbetasin acetate
1346423-89-9
-
Canagliflozin Formula
842133-18-0
-
Darifenacin Formula
133099-04-4
-
Propylthiouracil Formula
51-52-5
-
Testosterone, acetate Structure
1045-69-8
-
Dexamethasone acetate Structure
1177-87-3
-
What is Nateglinide
105816-04-4
-
What is Glimepiride
93479-97-1